Pediatric Vaccine Market 2026–2035 strengthening through immunization programs

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Pediatric Vaccine Market Expected To Change Between 2026 And 2030?

The pediatric vaccine market has seen rapid expansion over recent years. Projections indicate it will expand from $57.51 billion in 2025 to $65.01 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.0%. This historical growth can be ascribed to several factors, including the increasing incidence of preventable childhood diseases, immunization programs led by governments, advancements in vaccine adjuvants, a rise in pediatric health awareness, and the development of cold chain infrastructure.

The pediatric vaccine market size is projected to experience swift expansion over the coming years. It is anticipated to reach $107.8 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.5%. This anticipated growth during the forecast period can be attributed to several factors, including advancements in mRNA and DNA vaccine technologies, increased funding for pediatric vaccine research and development, the integration of digital health monitoring systems, the development of healthcare infrastructure in emerging markets, and collaborations between biotechnology companies and international health bodies. Key trends identified for the forecast timeframe encompass a heightened emphasis on ensuring vaccine availability in low-income areas, the growing uptake of combination vaccines, the broadening of school-based immunization initiatives, the creation of new pediatric vaccines to address rare conditions, and an increase in public-private sector alliances for vaccine research.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2824&type=smp

Which Economic Or Industry Drivers Are Impacting The Pediatric Vaccine Market?

The expansion of the pediatric vaccine market is significantly influenced by the escalating occurrence of chronic diseases, such as tuberculosis, diphtheria, and pneumonia, in individuals aged 15 years and below. Children and adolescents living with chronic conditions face a heightened risk of developing severe outcomes and complications from infectious diseases. Illustratively, data from June 2024, sourced from the National Health Service, a UK-based government department, indicated that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023. This marked an 18% increase from 3,065,825 cases recorded in 2022. Broadly, the increasing prevalence of pediatric diseases, defined as disorders affecting children from infancy to puberty that can be acute or chronic and range from moderate to severe, is anticipated to drive growth in the pediatric vaccine market. Pediatric vaccinations are vital for the prevention and control of a wide array of these disorders, safeguarding newborns and children from numerous infectious illnesses. For instance, according to GOV.UK, a UK-based government department, in February 2024, cases of tuberculosis (TB) in England experienced a 10.7% increase in 2023, rising to 4,850 from 4,380 in 2022. Thus, the growing prevalence of pediatric diseases serves as a key driver for the pediatric vaccine market.

How Is The Pediatric Vaccine Market Structured Across Different Segments?

The pediatric vaccine market covered in this report is segmented –

1) By Vaccine Type: Monovalent, Multivalent

2) By Technology: Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies

3) By Application: Infectious Disease, Allergy, Cancer

Subsegments:

1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines

2) By Multivalent: Combination Vaccines, Polyvalent Vaccines

Which Trends Are Shaping The Future Of The Pediatric Vaccine Market?

Major companies operating in the pediatric vaccine market are prioritizing product authorizations to more effectively address the demands of their existing consumers. ABRYSVO is a vaccine sanctioned by the FDA for use in pregnant women to prevent lower respiratory tract disease (LRTD) and severe LRTD triggered by respiratory syncytial virus (RSV) in children up to 6 months of age. For instance, in August 2023, Pfizer Inc., a US-based pharmaceutical manufacturing company, announced the U.S. FDA approval of Pfizer’s ABRYSVO vaccine for the Avoidance of Respiratory Syncytial Virus (RSV) in Infants through the active immunization of pregnant women 32-36 weeks gestational age. This is the first and only maternal vaccination approved in the United States designed to help protect newborns against lower respiratory tract illness (LRTD) and severe LRTD caused by RSV from birth to six months of age.

Which Major Players Dominate The Pediatric Vaccine Market?

Major companies operating in the pediatric vaccine market are Merck & Co. Inc., Serum Institute of India Pvt. Ltd., Sanofi SA, Pfizer Inc., GlaxoSmithKline PLC, Sinovac Biotech Ltd, Zydus Cadila, Indian Immunologicals Limited, Panacea Biotec, Takeda Pharmaceutical Company, Daiichi Sankyo, CSL Limited, Sinopharm, Walvax Biotechnology, Fosun Pharma, MCM Vaccine Company, Seqirus, Johnson & Johnson, Connaught Laboratories Inc., Wyeth-Ayerst, Ataulfo de Paiva Foundation, Bio-Manguinhos – Institute of Technology on Immunobiologicals, Butantan Institute, Ezequiel Dias Foundation (FUNED), Sinergium

Read the full pediatric vaccine market report here:

https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

What Are The Top-Performing Regions Within The Pediatric Vaccine Market?

North America was the largest region in the pediatric vaccine market in 2025. Middle East is expected to be the largest growing region in the global pediatric vaccine market share during the forecast period. The regions covered in the pediatric vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Pediatric Vaccine Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2824&type=smp

Browse Through More Reports Similar to the Global Pediatric Vaccine Market 2026, By The Business Research Company

Pediatric Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Adult Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795